Insunova N (rDNA Human Insulin Isophen)

K13,000.00
Pack Size: 10ml Vial

အင်ဆူနိုဗာ အန် သည်( အိုင်ဆိုဖင်း) အင်ဆူလင်အမျိုးအစားထိုးဆေးဖြစ်ပါသည်။ဆီးချိုရောဂါအမျိုးအစား၂ ကိုကုသရန်အသုံးပြုပါသည်။ဆရာဝန်ညွှန်ကြားချက်အတိုင်းအသုံးပြုသင့်ပါသည်။

The hypoglycemic effect of insulin is due to the uptake of glucose after insulin binds to receptors on muscle and fat cells, and also inhibits glucose production in the liver. The half-life of insulin in the blood is a few minutes.
 

Therefore, the duration of action of insulin preparation is only determined by its absorption properties. This process is influenced by a number of factors (eg insulin dose, route, and injection site), which is why it is important to consider variation per patient and between patients. Insulin is metabolized in the liver and kidney, a small amount is metabolized in the muscle and adipose tissue.

It binds to receptors on the cell surface, is introduced into the cells, and is then degraded by the insulin enzyme glutathione transhydrogenase to A and B chains and by specific intracellular protease. When Insunova N is injected subcutaneously, the onset of action occurs within 1 - 1.5 hours after injection, peak concentrations are reached from 4-8 hours, duration of action up to 24 hours. The average course of action after subcutaneous Insunova -N (NPH) is as follows:

The onset of action: within 1 - 1.5 hours.
 

Maximum impact: 4-8 hours.